Evidence map›Paper›PMID 39836014›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2025

Secondhand vape exposure regulation of CFTR and immune function in cystic fibrosis.

Benjamin L Wisniewski, Mahesh Shrestha, Dinesh Bojja, Chandra L Shrestha, Chris S Lee, Hazel Ozuna, Rachael E Rayner, Shasha Bai, Estelle Cormet-Boyaka, Susan D Reynolds and 1 more

Abstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Benjamin L WisniewskiSection of Pediatric Pulmonology & Sleep Medicine, Department of Pediatrics, University of Colorado Anschutz Medical Campus & Children's Hospital Colorado, Aurora, Colorado, United States.
Mahesh ShresthaDivision of Pulmonology, Asthma, Cystic Fibrosis, and Sleep, Emory University School of Medicine, Atlanta, Georgia, United States.
Dinesh BojjaDivision of Pulmonology, Asthma, Cystic Fibrosis, and Sleep, Emory University School of Medicine, Atlanta, Georgia, United States.
Chandra L ShresthaThe Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States.
Chris S LeeDivision of Pulmonology, Asthma, Cystic Fibrosis, and Sleep, Emory University School of Medicine, Atlanta, Georgia, United States.
Hazel OzunaDivision of Pulmonology, Asthma, Cystic Fibrosis, and Sleep, Emory University School of Medicine, Atlanta, Georgia, United States.
Rachael E RaynerSchool of Veterinary Medicine, The Ohio State University, Columbus, Ohio, United States.ORCID 0000-0002-0659-559X
Shasha BaiDivision of Innovation Research, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States.
Estelle Cormet-BoyakaSchool of Veterinary Medicine, The Ohio State University, Columbus, Ohio, United States.ORCID 0000-0001-9839-384X
Susan D ReynoldsThe Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States.
Benjamin T KoppDivision of Pulmonology, Asthma, Cystic Fibrosis, and Sleep, Emory University School of Medicine, Atlanta, Georgia, United States.ORCID 0000-0002-2021-7990

Funding

The role of CFTR during macrophage-mediated killing of bacteriaR01HL148171 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI Emanuela Marina Bruscia, Benjamin T Kopp · 2020 to 2026
$2.7M
Resue of CF phagocyte function with CFTR modulator therapyR01HL158747 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI GUGLANI, LOKESH, KOPP, BENJAMIN T · 2022 to 2025
$2.1M
Cystic Fibrosis Foundation (CFF) KOPP20P0-CIHHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL158747HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01HL148171NHLBI NIH HHS R01 HL148171NHLBI NIH HHS R01 HL158747
6 · The paper itself

Abstract

Secondhand smoke exposure (SHSe) is a public health threat for people with cystic fibrosis (CF) and other lung diseases. Primary smoking reduces CF transmembrane conductance regulator (CFTR) channel function, the causative defect in CF. We reported that SHSe worsens respiratory and nutritional outcomes in CF by disrupting immune responses and metabolic signaling. Recently, electronic cigarette (e-cigs) usage by caregivers and peers has increased rapidly, causing new secondhand e-cig vape exposures. Primary vaping is associated with immunologic deficits in healthy people, but it is unknown whether e-cigs similarly impacts CF immune function or how it differs from SHSe. Human CF and non-CF blood monocyte-derived macrophages (MDMs) and bronchial epithelial cells (HBECs) were exposed to flavored and unflavored e-cigs. The effect of e-cigs on CFTR expression and function, bacterial killing, cytokine signaling, lipid mediators, and metabolism was measured during treatment with CFTR modulators. E-cigs decreased CFTR expression and function in CF and non-CF MDMs and negated CFTR functional restoration by elexacaftor/tezacaftor/ivacaftor (ETI). E-cigs also negated the restoration of anti-inflammatory PGD

Indexed as

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorTobacco Smoke PollutionVapingAminophenolsBenzodioxolesCytokinesElectronic Nicotine Delivery SystemsEpithelial CellsHumansIndolesMacrophagesQuinolonesAminophenolsBenzodioxolesCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorCytokinesIndolesQuinolonesTobacco Smoke Pollutioncystic fibrosisinflammationmodulatorsomicsvaping

Identifiers

PMID39836014
PMCPMC12164564

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.